Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.
Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P.
Cancer Cell. 2006 Sep;10(3):241-52.
Similar articles
A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome.
Achanta G, Modzelewska A, Feng L, Khan SR, Huang P.
Mol Pharmacol. 2006 Jul;70(1):426-33. Epub 2006 Apr 24.
Anticancer activities of novel chalcone and bis-chalcone derivatives.
Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR.
Bioorg Med Chem. 2006 May 15;14(10):3491-5. Epub 2006 Jan 24.
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma.
Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, Keating MJ, Huang P.
EMBO J. 2005 Oct 5;24(19):3482-92. Epub 2005 Sep 15.
Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents.
Achanta G, Huang P.
Cancer Res. 2004 Sep 1;64(17):6233-9.
Superoxide dismutase: an emerging target for cancer therapeutics.
Hileman EA, Achanta G, Huang P.
Expert Opin Ther Targets. 2001 Dec;5(6):697-710.
Action of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on DNA metabolism: incorporation, excision, and cellular response.
Zhou Y, Achanta G, Pelicano H, Gandhi V, Plunkett W, Huang P.
Mol Pharmacol. 2002 Jan;61(1):222-9.
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage.
Achanta G, Pelicano H, Feng L, Plunkett W, Huang P.
Cancer Res. 2001 Dec 15;61(24):8723-9.
Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage.
Feng L, Achanta G, Pelicano H, Zhang W, Plunkett W, Huang P.
Int J Mol Med. 2000 Jun;5(6):597-604.
Filters: Manage Filters